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OBJECTIVES We investigated whether cardiac resynchronization therapy (CRT) affects myocardial glucose
metabolism and perfusion in dilated cardiomyopathy (DCM) and left bundle branch block
(LBBB).
BACKGROUND Patients with DCM and LBBB present with asynchronous left ventricular (LV) activation,
leading to reduced septal glucose metabolism. Cardiac resynchronization therapy recoordi-
nates LV activation, but its effects on myocardial glucose metabolism and perfusion remain
unknown.
METHODS In 15 patients (10 females; 61 13 years) with DCM and LBBB (QRS width 165 15 ms),
gated 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and technetium-
99m (99mTc)-sestamibi single-photon emission computed tomography were performed
before and after two weeks of CRT. Uptake of FDG and 99mTc-sestamibi was determined
in four LV wall areas. Ejection fraction and volumes were calculated from gated PET.
RESULTS Baseline FDG uptake was heterogeneous (p  0.0001), with lowest uptake in the septal
region (56  12%) and highest uptake in the lateral region (89  6%). During CRT, septal
and anterior increases (p  0.01) and lateral decreases (p  0.01) resulted in homogeneously
distributed glucose metabolism. Baseline heterogeneity (p  0.0001) in 99mTc-sestamibi
uptake was modest (lowest septal 65  10%; maximum lateral 84  5%) and also reduced
with CRT, although some heterogeneity (p  0.05) remained. The septal-to-lateral ratio
increased with CRT for FDG (0.62  0.12 to 0.91  0.26, p  0.001) and 99mTc-sestamibi
uptake (0.77  0.13 to 0.85  0.16, p  0.01). The LV end-diastolic and end-systolic
volumes decreased from 293  160 to 272  158 ml (p  0.05) and from 244  164 to 220
 160 ml (p  0.01), respectively. Ejection fraction increased from 22  12% to 25  13%
(p  0.01).
CONCLUSIONS Glucose metabolism is reduced more than perfusion in the septal compared with LV lateral
wall in patients with DCM and LBBB. Cardiac resynchronization therapy restores homo-
geneous myocardial glucose metabolism with less influence on perfusion. (J Am Coll
Cardiol 2003;41:1523–8) © 2003 by the American College of Cardiology Foundation
Patients with heart failure (HF) due to dilated cardiomy-
opathy (DCM) frequently present with left bundle branch
block (LBBB), causing delayed activation of the left ventri-
cle (LV). Experimental data indicate that LV activation
delay is associated with reduced septal glucose metabolism
(1). This experimental observation was recently confirmed
in humans with DCM and LBBB (2). Early septal contrac-
tion against a relaxed LV, with resultant decreasing aden-
osine triphosphate requirements, is discussed as the patho-
physiologic correlate (3). Reports on resting septal perfusion
in patients with LBBB are contradictory. They range from
diminished to normal perfusion, as estimated with thallium-
201 or technetium-99m (99mTc) compounds with single-
photon emission computed tomography (SPECT) or 13N-
ammonia positron emission tomography (PET) (2,4–8).
Cardiac resynchronization therapy (CRT) recoordinates
ventricular activation by atrial synchronous left or biven-
tricular pacing. Hemodynamic improvement with CRT has
been demonstrated in HF patients with LBBB (9,10).
However, the effects of CRT on regional myocardial glucose
metabolism and perfusion remain unknown.
Gated PET using 18F-fluorodeoxyglucose (FDG) enables
noninvasive measurement of myocardial glucose metabolism
and calculation of LV volumes and ejection fraction
(LVEF), whereas myocardial perfusion can be measured by
99mTc-sestamibi SPECT. Thus, the aim of the present
study was to investigate whether the hemodynamic benefit
of short-term CRT is paralleled by normalization of the
unbalanced regional myocardial glucose metabolism and
whether CRT affects regional myocardial perfusion in
patients with DCM and LBBB.
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METHODS
Patients. We investigated 15 patients with DCM (10
females; age 61  13 years; body weight 73  14 kg) with
HF (all in New York Heart Association functional class III)
and LBBB. All patients were in sinus rhythm with a mean
PR interval of 200  41 ms (range 165 to 310) and a mean
QRS width of 165  15 ms (range 140 to 200). Coronary
artery disease was ruled out in all patients by preoperative
coronary angiography. Patients received a resynchronization
pacemaker for biventricular (n  13) or LV (n  2) pacing.
Left ventricular pacing leads were positioned in a lateral
(n  12) or anterolateral position (n  3). The mean
programmed atrioventricular delay was 105  17 ms.
Patients were examined with FDG-PET and 99mTc-
sestamibi SPECT immediately before and 14 days after
CRT initiation. They fasted on the study days and received
optimized medical HF treatment, which was unchanged
during the entire study.
The study was approved by the institutional Review
Committee, and patients gave written, informed consent to
participate in the trial.
FDG-PET. To reduce myocardial fatty acid metabolism
and stimulate insulin-dependent glucose uptake, all patients
received 250 mg acipimox 2 h and 50 g glucose orally 1 h
before administration of FDG. Gated FDG-PET scans
(ECAT EXACT 922/47, Siemens-CTI, Knoxville, Ten-
nessee) were performed 60 min after intravenous adminis-
tration of 284  30 MBq FDG, with eight gates per RR
interval. The acquisition time was 30 min for emission
(two-dimensional mode) and 15 min for transmission
(68Ge/68Ga rod sources). The eight sinograms of the gated
acquisition were added up to create one ungated sinogram,
and attenuation-corrected gated and ungated images were
reconstructed using an iterative algorithm (Ordered Subsets
Expectation Maximization [OSEM], 16 subsets, 6 steps).
For ungated and gated images, the matrix size was 128 
128 pixels and 64  64 pixels and the reconstruction zoom
was 2.15 and 1.78, respectively.
99mTc-sestamibi SPECT. Myocardial perfusion SPECT
imaging was performed 60 min after injection of 424  17
MBq 99mTc-sestamibi, with a light meal after tracer appli-
cation. Data were acquired using a dual-head gamma
camera (Solus, ADAC Laboratories, Milpitas, California).
Acquisition parameters, attenuation- and scatter-corrected
reconstruction in a 128  128 matrix were described in
detail elsewhere (11). Briefly, emission was performed in
three independent energy windows: 140  14 keV for
emission, 120  6 keV for scatter detection, and 90  11
keV for backscatter detection. Data sets of windows 1 and 2
were processed to obtain a scatter-corrected data set, which
was then reconstructed using a Butterworth filter (cutoff 0.7
Nyquist, order of 5, matrix 128  128) and processed with
the data set of window 3 (filtered backprojection, Ramp 0.5)
to obtain a final segmented attenuation- and scatter-
corrected transaxial data set.
PET and SPECT analyses. Ungated FDG and 99mTc-
sestamibi images were reoriented according to the LV axes.
Relative distributions of myocardial FDG and 99mTc-
sestamibi uptake values were assessed using a volumetric
vector sampling method in 25 segments. Segmental FDG
and 99mTc-sestamibi uptake was displayed as the percentage
of the segment with peak activity. Mean FDG and 99mTc-
sestamibi uptake of four LV wall areas (septal, anterior,
lateral, and posterior)—each consisting of six segments—
was calculated as the mean value of the respective six
segments for every patient. Due to possible ambiguous
assignment, the remaining apical segment was not included
in the wall area analysis. The septal-to-lateral ratios were
determined as septal FDG or 99mTc-sestamibi uptake di-
vided by the uptake values of the lateral wall. Figure 1
displays representative examples of FDG-PET and 99mTc-
sestamibi SPECT images, as well as individual uptake
values, at baseline and during CRT in a 50-year-old female
patient with severe LV dilation due to nonischemic cardio-
myopathy.
The pixel size of gated FDG images was changed to an
isotropic pixel size of 5.79 mm. These data were reoriented
and analyzed for LV end-diastolic (LVEDV) and end-
systolic volumes (LVESV), as well as for LVEF, with the
software tool called Quantitative Gated SPECT (QGS,
Cedars-Sinai Medical Center, California).
Statistics. Statistical analyses were performed using SPSS
version 10 (SPSS Inc., Chicago, Illinois). Data are ex-
pressed as the mean value  SD. Dependencies of tracer
uptake on the different myocardial wall areas (i.e., differ-
ences of relative FDG and 99mTc-sestamibi uptake values
between septal, anterior, lateral, and posterior myocardium)
were analyzed using the nonparametric Kruskal-Wallis test.
This test was performed separately for both baseline and
CRT examinations. Differences between wall areas in their
responses over time, in terms of FDG or 99mTc-sestamibi
uptake values, were also assessed with the Kruskal-Wallis
test.
Intragroup comparisons (i.e., differences of mean values
before and during CRT) were tested for significance using a
nonparametric test for paired samples (Wilcoxon). Statisti-
Abbreviations and Acronyms
CRT  cardiac resynchronization therapy
DCM  dilated cardiomyopathy
FDG  18F-fluorodeoxyglucose
HF  heart failure
LBBB  left bundle branch block
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LVESV  left ventricular end-diastolic and end-
systolic volume, respectively
LVEF  left ventricular ejection fraction
PET  positron emission tomography
SPECT  single-photon emission computed
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cal analyses of differences between FDG and 99mTc-
sestamibi in their uptake values, septal-to-lateral ratios and
corresponding changes over time were performed with a
nonparametric test for independent samples (Mann-
Whitney U test). A p value 0.05 was considered signifi-
cant.
RESULTS
Impact of CRT on myocardial glucose metabolism and
perfusion. At baseline, glucose metabolism in patients with
DCM and LBBB showed significant differences between
the analyzed myocardial wall areas (p  0.0001). Uptake
was highest in the lateral wall and lowest in the septum,
with intermediate values for the anterior and posterior wall
(Fig. 2A). Myocardial perfusion also showed significant
differences between the respective wall areas (p  0.0001),
although these were less marked than differences in glucose
metabolism (Fig. 2B).
99mTc-sestamibi uptake was significantly higher than
FDG uptake in the septum (65  10% vs. 56  12%, p 
0.05) and lower in the lateral wall (84  5% vs. 89  6%,
p  0.01). Accordingly, the mean septal-to-lateral ratio at
baseline was significantly lower for FDG (0.62 0.12) than
for 99mTc-sestamibi (0.77 0.13, p 0.001) (Figs. 2A and
2B).
During CRT, wall areas showed significantly different
responses in their FDG uptake (p  0.0001) and 99mTc-
sestamibi uptake (p  0.01). Glucose metabolism increased
significantly by 25% in the septum and 17% in the anterior
wall, whereas metabolism decreased significantly by 11% in
the lateral wall. Thus, glucose metabolism was homoge-
neously distributed in the LV myocardium and mean FDG
uptake values did not differ between the respective wall areas
(p  0.128) (Fig. 2A). The influence of CRT on regional
myocardial perfusion was less pronounced. Relative 99mTc-
sestamibi uptake increased by 6% in the septum and 8% in
the anterior wall. A reduced spatial heterogeneity of myo-
cardial perfusion between the respective wall areas (p 
0.05) remained, with lowest 99mTc-sestamibi uptake in the
septum and highest uptake in the lateral wall (Fig. 2B).
Consequently, mean septal-to-lateral ratios for FDG and
99mTc-sestamibi both increased significantly to 0.91  0.26
(p  0.001) and 0.85  0.16 (p  0.01), respectively,
although the relative increase was significantly (p  0.0001)
higher for FDG (47%) than for 99mTc-sestamibi (10%)
(Figs. 2A and 2B).
When the two patients with LV pacing were compared
with the 13 patients paced in the biventricular mode, both
baseline FDG and 99mTc-sestamibi uptake values and
changes during CRT were comparable between both pacing
modes. Uptake values of FDG and 99mTc-sestamibi before
and during CRT in the two LV-paced patients were also
substantively similar to those in all 15 patients.
Impact of CRT on LV function. At baseline, mean
LVEDV and LVESV were 293  160 and 244  164 ml,
respectively. After two weeks of CRT, LVEDV decreased
significantly to 272  158 ml (p  0.05) and LVESV to
220  160 ml (p  0.01). Mean LVEF increased from
22  12% at baseline to 25  13% after CRT (p  0.01).
DISCUSSION
Cardiac resynchronization therapy has been proposed as an
adjunctive treatment for patients with severe HF and
LBBB. Short-term hemodynamic (9,10,12) and long-term
functional improvements have been reported (13–15). The
benefit of CRT is achieved by improved chamber efficiency,
as demonstrated by a reduction in myocardial energy con-
sumption (16). Moreover, a reduction in LV volumes after
Figure 1. Example of 18F-fluorodeoxyglucose-positron emission tomography and technetium-99m-sestamibi single-photon emission computed tomog-
raphy images at baseline and during cardiac resynchronization therapy in a 50-year-old female patient with severe left ventricular dilation due to nonischemic
cardiomyopathy. Shown are representative short-axis and horizontal long-axis slices of 1.2 cm thickness, as well as individual uptake values of the respective
wall areas. A  anterior wall area; L  lateral wall area; P  posterior wall area; S  septal wall area.
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CRT has been observed in echocardiographic studies
(17,18).
Resynchronization of LV contraction by advancing LV
free wall activation has been implicated as one major
mechanism of CRT (19). The extent of the LV base
displaying delayed longitudinal contraction, as detected by
echocardiographic tissue Doppler imaging, has been shown
to predict the long-term efficacy of CRT. With tissue
tracking, improved regional longitudinal systolic shortening
during CRT could be demonstrated (20). Near-
simultaneous contraction of the septum and LV free wall
may lead to septal reloading during LV systole. This is
underscored by data provided by Kawaguchi et al. (21), who
used contrast-enhanced echocardiography to show that one
major mechanism of hemodynamic improvement with
CRT is an increase in septal inward motion. With the same
technique, these authors could also show a 40% reduction of
LV dyssynchrony with CRT.
The main finding of our study is that the reduction of
mechanical LV dyssynchrony by CRT is accompanied by
homogenization of the unbalanced cardiac glucose metab-
olism in DCM and LBBB, with less influence on myocar-
dial perfusion. Previous studies have shown a reduction in
septal glucose metabolism in patients with LBBB (2,22). In
contrast, results on resting perfusion abnormalities in LBBB
have not uniformly demonstrated a reduction in septal
perfusion (2,4–8,23). The results of our study indicate that
septal glucose metabolism is more reduced than perfusion,
Figure 2. Mean (SD) relative 18F-fluorodeoxyglucose (FDG) (A) and technetium-99m-sestamibi (B) uptake values of the four left ventricular wall areas,
as well as septal-to-lateral ratios at baseline and during cardiac resynchronization therapy (CRT) in 15 patients. *p  0.05, †p  0.01, and ‡p  0.001
compared with FDG.
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which is in good agreement with the postulated septal
reverse perfusion/glucose metabolism mismatch in LBBB
(2,22).
The most likely explanation for reduced septal glucose
uptake in LBBB is therefore a perfusion-independent spe-
cific alteration of transmembranous glucose transport and/or
the subsequent phosphorylation kinetics (24). This is un-
derscored by previous evidence for preserved septal viability
and metabolic activity associated with beta-oxidation and
oxygen consumption, as determined with the 18F-labeled
fatty acid 14(R,S)-18F-fluoro-6-thia-heptadecanoic acid
and with 11C-acetate in LBBB (25,26).
There is experimental evidence that early septal contrac-
tion against the relaxed LV free wall in LBBB reduces septal
work load, because pressure is still low and no ejection
occurs (27). On the other hand, late activation of the LV
lateral wall in patients with LBBB occurs at higher stress,
because the earlier activated septum has already developed
tension (21,28). Our data indicate that these known alter-
ations in ventricular mechanics result in corresponding
changes in myocardial glucose metabolism, as indicated by
the diminished baseline septal-to-lateral ratio of FDG
uptake.
Theoretically, reduced septal work load would entail
decreasing adenosine triphosphate requirements of the
septum, with concomitantly diminished glucose metabolism
(3). Depre et al. (29) provided indirect evidence for this
hypothesis by an animal model of unloaded rat hearts
being transplanted on the abdominal aorta of isogenic
recipients. Gene expression for the insulin-sensitive glucose
transporter GLUT-4 in these hearts decreased one day after
transplantation, resulting in myocardial insulin resistance,
characterized by a reduction of insulin-dependent myocar-
dial glucose oxidation in unloaded hearts (30). This flexible
regulation of cardiomyocyte gene expression could provide
the pathophysiologic basis for alterations in septal glucose
metabolism in the sense of septal insulin resistance in
patients with HF and LBBB, which is reversed by CRT.
Indeed, rapid re-expression of GLUT-4 occurred within 60
min when the energy needs increased upon reloading of rat
hearts (29).
Myocardial glucose metabolism in this study was mea-
sured after an oral glucose load, which is a stimulus for
insulin release. Thus, the observed reduction in septal
glucose metabolism and its reversal with CRT in our study
are well in accordance with the results on GLUT-4 mes-
senger ribonucleic acid expression and insulin resistance
observed in the model of unloaded and reloaded rat hearts
(29,30).
Conclusions. Glucose metabolism is reduced to a greater
extent than perfusion in the septum and adjacent anterior
and posterior LV wall in patients with DCM and LBBB.
The hemodynamic benefit of CRT is paralleled by restora-
tion of homogeneous myocardial glucose metabolism, with
less influence on perfusion.
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